Soft pastels · Free shipping over $75 · Shop the boutique
glp-1 receptor gene

glp-1 receptor gene Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Evolution of GLP‐1 Receptor Agonists

SKU: 67904380061

4.4
USD27.08 USD74.08

Pay in 4 interest-free payments of $6.77 Learn more

Shipping Estimate
USA
  • USA
  • CAN

Ships within 48 hours · Estimated delivery Sep 29 - Oct 4

Description

Key features include: 99% purity, confirmed by HPLC and mass spectrometry for analytical accuracy and research reproducibility Pentapeptide structurewith non-proteinogenic residues (Aib and D-amino acids) conferring exceptional metabolic stability and resistance to non-specific proteolytic degradation High receptor selectivitydemonstrating minimal activity on non-target pituitary hormones including ACTH, cortisol, prolactin, FSH, LH, and TSHdistinguishing it from less selective growth hormone secretagogues Potent GHS-R1a agonist activitywith ED = 2.3 nmol/kg in conscious animal models, comparable to GHRP-6 efficacy but with enhanced selectivity Lyophilized powder formatproviding extended shelf-life stability of up to 24 months when stored appropriately, with minimal degradation under recommended cold-storage conditions Widely utilized as a pharmacological tool compoundfor structure-activity relationship (SAR) investigations and receptor-ligand selectivity studies For laboratory research use only These properties support its use as ipamorelin for research across receptor pharmacology, endocrine signaling, and growth hormone axis investigations

glp-1 receptor gene Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Evolution of GLP1 Receptor Agonists

Insurance companies often cover Ozempic for diabetics but refuse to pay for Wegovy, making the former a more accessible option for those who can afford out-of-pocket costs or have specific medical needs

glp-1 receptor gene Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Evolution of GLP1 Receptor Agonists

What to do after getting a glutathione injection

glp-1 receptor gene Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Evolution of GLP1 Receptor Agonists

March 13, 2026: FDA Sends Warning Letter to Novo Nordisk The FDA has sent a warning letter to the maker of Ozempic and Wegovy over a potential failure to report side effects connected to these drugs

glp-1 receptor gene Agonists in Solid Tumour Therapy: Exploring Their Anticancer Potential and Underlying Molecular Pathways Evolution of GLP1 Receptor Agonists
Exchange/Return Notes
  • We offer a 30-day return/exchange service after receiving.
  • Final sale items are not eligible for returns or exchanges.
  • To process your return/exchange, please contact us at [email protected]
  • Please click here for more details>>> Return & Exchange Policy

You may also like

recommand products